Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab with surgery in Hidradenitis Suppurativa
NCT02808975Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2016
- Primary completion
- May 2019
- Modality
- Monoclonal Antibodies
- Countries
- 23
01
Overview
A Phase 4 trial of adalimumab in hidradenitis suppurativa (HS), sponsored by AbbVie Inc.. Started Jul 2016; status: completed.
02
Drugs
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT02808975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02808975.